One of the major diseases in Norway that affects Atlantic salmon during the seawater phase is cardiomyopathy syndrome (CMS). In 2017, the disease was reported at about 100 farms (out of \~1000 farms) along the coast of Norway ([@CIT0011]; [@CIT0016]). In most cases, no clinical signs are observed until the onset of mortality in relatively large fish (\~3.6 kg) several months after sea transfer. This leads to very large economic losses and reduced welfare of the fish ([@CIT0020]). Moreover, it has also been observed that the presence of the disease results in large secondary losses (mortality) when the fish undergoes minor stresses like treatment for sea lice infestation ([@CIT0011]). Cardiomyopathy syndrome is caused by the piscine myocarditis virus (PMCV) ([@CIT0015]) and the disease is diagnosed by histopathology of the heart which shows moderate to severe inflammation, mostly limited to the endocardium and spongy myocardium in the atrium and ventricle ([@CIT0028]). In addition, real-time PCR analysis of the heart, kidney, and spleen can be used to confirm the presence of the virus ([@CIT0031]).

Because there are no treatments or vaccines against the PMCV virus, husbandry practices (such as minimizing stressful management routines, e.g., lice and amoebic gill disease treatment) and some biosecurity measures are used to try to limit outbreaks and losses resulting from CMS ([@CIT0011]). An additional strategy is to increase the host resistance to the virus through selective breeding. Although the expected response per generation may be relatively small, the change in the host response is cumulative and permanent. In 2012, it was reported that there was variation between families for survival to CMS ([@CIT0001]); however, the estimate of heritability was not reported. Recently, using survival data from a field outbreak of CMS, [@CIT0090] reported heritability (liability scale) of 0.25 ± 0.04. Several authors have also reported medium to relatively high heritability for other disease resistance traits in Atlantic salmon (reviewed by [@CIT0022]; [@CIT0037]). When additive genetic variance for the trait is significant, it is possible to use genetic selection to increase the resistance of Atlantic salmon to diseases. For instance, selection for increased resistance to IPN in Atlantic salmon has resulted in considerable reduction in the number of outbreaks and economic losses ([@CIT0016]).

Controlled experimental challenge tests have been commonly used to assess disease resistance phenotypes for Atlantic salmon. But challenge tests require specialized dedicated facilities and can be expensive to perform. Numerous field outbreaks occur for many diseases such as CMS in any 1 year. The main challenge with the use of field outbreak data for estimating breeding values for disease resistance is that outbreak circumstances vary and the usefulness/quality of data collected will depend on the relationship of affected animals to the breeding population, the virulence of the disease strain, environmental conditions affecting spread of the disease, and susceptibility of the fish and the ability of the farm affected to detect the occurrence of the outbreak and to collect appropriate samples. Nonetheless, field outbreak data could potentially provide useful information about the resistance of the animal to infection under grow-out conditions on-farm, which could be quite different to the situation in tanks when fish are experimentally challenged using different modes of infection and doses of disease.

Over the last decade, large genomic resources for Atlantic salmon have been developed. These resources have been used to map several quantitative trait loci (QTL), improve our understanding of the underlying genetic basis of economically important traits and provide tools for more accurate and efficient selection of fish in breeding programs. Intensive efforts have been undertaken to discover the underlying genetic architecture of disease traits in Atlantic salmon such as infectious pancreas necrosis ([@CIT0017]; [@CIT0021]), pancreas disease ([@CIT0013]), amoebic gill disease ([@CIT0027]), and sea lice ([@CIT0032]). In addition to QTL mapping efforts and marker-assisted selection approaches, genomic selection (GS) approaches have been adopted to accelerate genetic progress, providing higher selection intensity and accuracy than family pedigree-based breeding programs. Although GS in family-based Atlantic salmon breeding programs is in its early phase (2 generations of selection), initial results from several breeding programs suggests positive gains for the selected traits ([@CIT0024]; [@CIT0032], [@CIT0033]; [@CIT0002]; [@CIT0006]; [@CIT0027]).

Therefore, the aims of this study were to: 1) estimate and compare the heritability of resistance to CMS in populations of Atlantic salmon that were infected by a natural outbreak and by experimental challenge test, 2) detect QTLs that could potentially be utilized for marker-assisted selection to improve resistance to CMS, and 3) identify genes closely mapped to QTL for CMS resistance.

Materials and Methods {#s1}
=====================

Populations {#s2}
-----------

Three different populations of fish were obtained from the Mowi breeding program and used in this study. The first population was 1) a commercial grow-out fish that came from the multiplier population and were naturally infected in the field (commercial cages). The other 2 populations were full- and half-sibs of the breeding candidates (informant) from the breeding program that were 2) naturally infected with the PMVC virus during an outbreak in the field and 3) challenge tested in a controlled facility with the PMCV virus.

Field Outbreak of a Commercial Population---Population 1 {#s3}
--------------------------------------------------------

In a commercial farm with approximately 190,000 fish in a single cage at Trøndelag, Norway, veterinarians confirmed an outbreak of CMS, through clinical signs and qPCR analysis of dead fish for the PMCV virus. The fish started feeding (start-feeding) in March 2016 and were transferred to sea cages in October 2016 at Lille Tørsoy, Trøndelag, Norway. We obtained 320 dead fish during the 6-week period of the CMS outbreak which started on January 2017. The dead fish were examined by veterinarians and were confirmed to be infected with the PMCV virus using quantitative polymerase chain reaction (qPCR) analysis. In April 2017, we also sampled 300 surviving fish that were critically examined and not found to be infected with the PMCV virus after mortalities had ceased. A binary phenotype was analyzed, with dead fish coded as 0 and fish that were sampled and examined to be PMCV virus free coded as 1.

Informant Population (natural infection)---Population 2 {#s4}
-------------------------------------------------------

A total of 5115 eyed-eggs generated from 173 sires and 341 dams (15 eye-eggs per family) were pooled and reared together until hatching. After hatching in April 2014, the fish started feeding (start-feeding) and were communally reared until tagging. A total of 4667 (\~13 fish per family) fish were pit-tagged at an average weight of 68 g. After smoltification (a process in which the fish undergoes structural and functional transformation to prepare for the transfer from fresh water to seawater) in May 2015 (at an average weight of 97 g), the fish were transferred to sea cages at Averøy, Norway. Examination of the dead fish was performed daily, and when diseases were suspected, veterinarians determined the cause of death using clinical signs and qPCR tests. The fish were full- and half siblings of the breeding candidate that were to be raised until harvest weight and recorded for slaughter traits (e.g., harvest weight, fillet color, fillet fat, etc.), however, they were infected with CMS through a natural outbreak. The PMCV virus was first detected 10 months after sea transfer when the fish with the test being tested positive for the virus after qPCR analysis. During a routine thermo-lice treatment of the fish, large numbers of mortalities were recorded, and each dead fish was collected and examined to ascertain the cause of death. Veterinarians checked for signs of edema and fibrin in the liver and spleen as well as congestion (filled with blood and fluid) and hemorrhage of the atrium. The mortalities in the entire seawater phase until slaughter were categorized as 1) unknown causes and 2) CMS-related mortalities. The total number of fish that died up until harvest (4.1 ± 1.1 kg) was 1190 (unknown = 776; CMS = 414). When analyzing this dataset, we coded the 414 fish that died with symptoms of CMS as 0; the 776 fish with unknown cause of mortality as missing and the 3477 (= 4667--1190) slaughtered fish as 1 (i.e., survivors to the PMCV virus).

Informant Population (challenge tested)---Population 3 {#s5}
------------------------------------------------------

A total of 1095 eyed-eggs were generated from 32 sires and 73 dams (15 eye-eggs per full-sibling family) and were challenged with the PMCV virus. The mating ratio consisted of 1 male to 2 females (65%) and 1 male to 3 females (35%). After hatching in April 2016, the fish were start fed and communally reared. In April 2017, the fish were smoltified before being transported from Mowi facilities at Øyerhamn, Norway to VESO Vikan, Namsos, Norway for the challenge test in May 2017. After 2 weeks of acclimatization, they were challenged tested through an intraperitoneal injection of the PMCV virus that originated from a highly virulent field outbreak of CMS, which was confirmed by qPCR analysis. At the end of the challenge period (9 weeks), heart tissues were obtained from each fish for histopathology analysis was undertaken as described under population 2. Histopathology of heart tissues was undertaken by the FishVet Group, Norway (<http://fishvetgroup.no/en/>). Both the atrium and ventricular tissue was examined for damage using the scoring system described in [Table 1](#T1){ref-type="table"}, with a score of 0 representing no visible lesions to a score of 3 which represented \>50% of the heart tissue showing confluent lesions. Only histology scores of the atrium were used as the phenotype in this population because we obtained similar results using ventricular histology scores.

###### 

Scoring scheme for the histology of heart (atrium) tissue affected by cardiomyopathy syndrome

  Score   Description
  ------- -------------------------------------------------------------------------------------------------
  0       No histopathological findings
  1       Few (\<7) focal lesions
  2       Several distinct lesions and increased mononuclear infiltration
  3       Multifocal to confluent lesions in \>50% of tissues + moderate -- severe leukocyte infiltration

Genotyping and Quality Control {#s6}
------------------------------

DNA was extracted from fin clips of all the fish using commercial kits by IdentiGEN, Ireland.). A total of 5940 samples (620, 4350, and 985 from population 1, 2, and 3, respectively) were genotyped with a ThermoFisher Axiom 57K single nucleotide polymorphism (SNP) array (NOFSAL03, 55735 markers) that was developed by Nofima in collaboration with Mowi and SalmoBreed. Genotyped samples were quality checked within population with PLINKv1.9 ([@CIT0005]) using the following procedure: Samples and SNPs with a call rate \<95% were discarded. SNPs with Hardy Weinberg *P*-value (Fishers exact test) \<10^--15^ and those with minor allele frequency \<2% were removed. Samples that were \<25% and \>47% heterozygous were discarded. After genotype quality checks the total number of samples (markers in bracket) that were used for further analysis were 571 (54498), 4312 (53738), and 901 (53678) for population 1, 2, and 3, respectively.

Statistical Analysis {#s7}
--------------------

### (Co)variance Estimations {#s8}

Variance and covariance components were estimated with genomic relationships instead of pedigree information to be able to estimate the genetic correlations between the 3 populations. The following linear mixed animal model was applied:
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where $y_{1}$(binary -- dead = 0 and survived = 1), $y_{2}$ (binary -- dead = 0 and survived = 1) and $y_{3}$(histology scores ranged from 0 to 3) are vectors of phenotypes for the animals in population 1, 2, and 3, respectively; $X_{1}$, $X_{2}$, and $X_{3}$ are incidence matrices relating the phenotypic records to their respective mean ($\mu_{1}$, $\mu_{2}$, and $\mu_{3}$) of the 3 population; $Z_{1}$, $Z_{2}\ $, and $Z_{3}$ are incidence matrices linking the phenotypes in each population to their genomic breeding values ($g_{1}$, $g_{2}$ and $g_{3}$); $e_{1}$, $e_{2}$ and $e_{3}$ are vectors containing the random residual effects for the 3 populations. Genomic breeding values were assumed to follow a multivariate normal distribution $\left. \begin{bmatrix}
g_{1} \\
g_{2} \\
g_{3} \\
\end{bmatrix} \right.\sim~mvn\left( {~\begin{bmatrix}
0 \\
0 \\
0 \\
\end{bmatrix},~K~ \otimes \left\lbrack {\begin{matrix}
\sigma_{g1}^{2} \\
\sigma_{g12} \\
\sigma_{g13} \\
\end{matrix}~\begin{matrix}
\sigma_{g12} \\
\sigma_{g2}^{2} \\
\sigma_{g23} \\
\end{matrix}~\begin{matrix}
\sigma_{g13} \\
\sigma_{g23} \\
\sigma_{g3}^{2} \\
\end{matrix}} \right\rbrack} \right)$, where $\sigma_{g1}^{2}$, $\sigma_{g2}^{2}$ and $\sigma_{g3}^{2}$ are the genetic variances for population 1, 2, and 3, and $\sigma_{g12}$, $\sigma_{g13}$, and $\sigma_{g23}$ were the genetic covariances between the populations. The multipopulation genomic relationship matrix ($K$) was computed following the approach described by [@CIT0036] as:
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where $W_{1}$, $W_{2}$, and $W_{3}$ contains the centered genotypes of population 1, 2, and 3. The marker genotypes coded as 0 (AA), 1 (AB \| BA) and 2 (BB) were centered with the observed allele frequency of each population, where $p_{1i}$ ($q_{1i} = 1 - p_{1i}$), $p_{2i}$ ($q_{2i} = 1 - p_{2i}$), and $p_{3i}$ ($q_{3i} = 1 - p_{3i}$) are the allele frequencies of marker $i$ for population 1, 2, and 3, respectively. Residual effects were assumed to be normally distributed but with no residual covariance between the populations such that $\left. \begin{bmatrix}
e_{1} \\
e_{2} \\
e_{3} \\
\end{bmatrix} \right.\sim~N\left( {~\begin{bmatrix}
0 \\
0 \\
0 \\
\end{bmatrix},~\left\lbrack {\begin{matrix}
{I\sigma_{e1}^{2}} \\
0 \\
0 \\
\end{matrix}~\begin{matrix}
0 \\
{I\sigma_{e2}^{2}} \\
0 \\
\end{matrix}~\begin{matrix}
0 \\
0 \\
{I\sigma_{e3}^{2}} \\
\end{matrix}} \right\rbrack} \right)$, where $I$ was an identity matrix and $\sigma_{e1}^{2}$, $\sigma_{e2}^{2}$, and $\sigma_{e3}^{2}$ were the residual variances for population 1, 2, and 3. The genetic and residual (co)variances were estimated in ASREML v4 software ([@CIT0012]).

### Marker Association Analysis {#s9}

Genome-wide association analysis was performed using a linear mixed animal model approach for each of the population separately. To account for genetic stratification ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}) within each of the populations, the first 5 eigenvectors from a principal component analysis ([@CIT0005]) were used as covariates. The following model was used
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where $y$ are either the binary phenotypes for population 1 and 2 or the histology scores for population 3, $\mu$ is the overall mean$,\underset{j = 1}{\overset{N=5}{\sum}}\, eigenvec_{j}$ are the first 5 eigenvectors, $M_{i}$ is the incidence matrix for marker $i$ containing marker genotypes, $\alpha_{i}$ is the allele substitution effect of marker $i$, $Z$ was the incidence matrix linking phenotypes to their genomic breeding values ($g$) and was assumed to follow normal distribution $\sim N(0,G\sigma_{g}^{2})$, where, $G$ is the genomic relationship matrix constructed for each population and was equivalent to the diagonal block of the $K$ matrix, and $e$ is the vector of random residual effects which followed a normal distribution $\sim N(0,I\sigma_{e}^{2})$, where, $I$ was an identity matrix and $\sigma_{e}^{2}$ was the residual variance. The analysis was undertaken with GCTA ([@CIT0038]) using the "\--mlma-loco" approach which ensures that the effect of marker $i$ is estimated by accounting for the additive genetic variance ($\sigma_{g}^{2}$) and relationships captured by chromosomes other than the one the marker is located. Markers were considered significant when they exceeded the Bonferroni threshold for multiple testing of 0.05 divided by the number of markers that passed the quality check for that population. To quantify the level of inflation (lambda) of the observed $p$-values compared to the expected $p$-values, we computed lambda ($\lambda$) as $\frac{median\ \left( \left( \alpha^{2}/s.e^{2} \right)^{2} \right)}{0.456}$ ([@CIT0034]) and the results were presented in a quantile--quantile (Q--Q) plots. The proportion of total genetic and phenotypic variance explained by significant markers was computed from the estimated allele substitution effects ($\alpha$) and allele frequencies of each marker as: $Vg = \frac{2p_{i}(1 - p_{i})\alpha_{i}^{2}}{\sigma_{g}^{2}}$ and$\ Vp = \frac{2p_{i}(1 - p_{i})\alpha_{i}^{2}}{\sigma_{p}^{2}}$.

### Bioinformatics and Candidate Genes {#s10}

SNPs passing a genome-wide significance threshold ($- log_{10}P = 6.03$) were further examined to identify genes potentially involved in CMS resistance. Bedtools (v2.26.0) was used to identify the SNP position relative to the closest gene or genes. This was conducted by making a bed file from the SNP positions and using intersectBed with the Atlantic salmon genome version 2.2 (<https://www.ncbi.nlm.nih.gov/assembly/GCF_000233375.1/>). Further investigation of the genes involved was conducted using NCBI resources (BLAST, Gene, and Pubmed) and the potential effect of SNPs within exons was assessed by translating each SNP variant using ExPASy Translate tool (<https://web.expasy.org/translate/>) and the predicted protein sequences from NCBI.

Results {#s11}
=======

Phenotypic Distribution {#s12}
-----------------------

To maximize power to detect possible QTLs associated with resistance to the PMCV virus, we sampled approximately equal numbers of dead and surviving fish from population 1, however, after genotype quality checks, the percentage of dead fish was slightly higher (55.7%) than the surviving fish that were sampled (44.3%, [Figure 1A](#F1){ref-type="fig"}). For population 2 (an informant population which encountered a natural outbreak of the PMCV virus), only 402 fish (9.3%) out of 4312 died from the CMS outbreak, the rest of the population (90.7%, [Figure 1B](#F1){ref-type="fig"}) were considered as survivors and used in the analysis. Since the PMCV challenge test model did not result in mortalities, we performed histology of the heart (atrium) for all the challenge tested fish. The mean histology score was 1.750 (SD = 0.680), however, 86.2% of all fish had either a score of 1 (22.3% with no histopathological findings) or a score of 2 (63.9% with few (\<7) focal lesions, [Figure 1C](#F1){ref-type="fig"}).

![Distribution of traits in the 3 population. (**A**) Binary phenotype (dead or survived) recorded in population 1, (**B**) binary phenotype (dead or survived) recorded in population 2, and (**C**) heart tissue (atrium) histology scores (0 to 3) recorded in population 3.](esz042f0001){#F1}

Heritability and Genetic Correlation Between the Populations {#s13}
------------------------------------------------------------

Heritability estimates for survival to PMCV in population 1 and 2 were 0.383 ± 0.076 and 0.117 ± 0.018, respectively ([Table 2](#T2){ref-type="table"}). A higher heritability (0.464 ± 0.055) was obtained for histopathological score of the atrium in the controlled challenge test of population 3 ([Table 2](#T2){ref-type="table"}).

###### 

Variance components and heritability estimate (standard error; in bracket) for the 3 populations

  Parameters         Field outbreak                          Challenge test Population 3
  ------------------ ------------------- ------------------- -----------------------------
  $\sigma_{g}^{2}$   0.097 (0.023)       0.010 (0.002)       0.226 (0.038)
  $\sigma_{e}^{2}$   0.157 (0.017)       0.076 (0.002)       0.262 (0.020)
  $\sigma_{p}^{2}$   0.254 (0.017)       0.086 (0.002)       0.488 (0.031)
  $h^{2}$            **0.383 (0.076)**   **0.117 (0.018)**   **0.464 (0.055)**

$\sigma_{g}^{2}$, genetic variance; $\sigma_{e}^{2}$, residual variance; $\sigma_{p}^{2}$, phenotypic variance; $h^{2}$, heritability; binary phenotype (dead = 0 and survived = 1) was used in population 1 and 2, histology score of the heart (atrium) was the recorded phenotype in population 3.

The estimated genetic correlation (using the genomic relationship matrix) between survival to PMCV in population 1 and population 2 was moderate (0.609 ± 0.225; [Table 3](#T3){ref-type="table"}). The genetic correlation between survival (population 1 and 2) and histology scores (population 3) was favorable and ranged from −0.514 ± 0.190 to −0.593 ± 0.265 ([Table 3](#T3){ref-type="table"}). The estimates of heritability and genetic correlations between the populations were all significantly different from zero (*P*\<0.05) based on a likelihood ratio test (results not presented).

###### 

Genetic correlations (standard error) between the binary survival traits (Production and Informant populations) and the atrium-score trait (Challenge test population)

  ----------------------------------------------------------------
  Populations                    1\               2\
                                 Production       Informant
  ------------- ---------------- ---------------- ----------------
  1             Production                        

  2             Informant        0.611 (0.225)    

  3             Challenge test   −0.593 (0.262)   −0.514 (0.190)
  ----------------------------------------------------------------

Marker Association {#s14}
------------------

We detected 24 and 186 markers on chromosome 12 and 27, respectively that exceeded the genome-wide Bonferroni significance level ($- log_{10}P = 6.03$; [Figure 2](#F2){ref-type="fig"} and [Supplementary File 2](#sup2 sup3){ref-type="supplementary-material"}). The putative QTL on chromosome 12 was present in population 1 and 3 but not in population 2, while the QTL on chromosome 27 was present in all 3 populations ([Figure 2A--C](#F2){ref-type="fig"}). The observed *P*-values were inflated ($\lambda$ of \~1.1 indicates relatively good concordance between observed and the assumed distributions of the test statistic) with lambda values ranging from 1.08 to 1.23 ([Figure 3](#F3){ref-type="fig"}). When the most significant SNP was included as a covariate, one at a time for each QTL region and population, to investigate the possibility of multiple QTLs in any of the regions on chromosome 12 and 27, none of the surrounding SNPs showed associations with the trait ([Figure 4b](#F4){ref-type="fig"},[d](#F4){ref-type="fig"},[f](#F4){ref-type="fig"},[h](#F4){ref-type="fig"}, and [j](#F4){ref-type="fig"}).

![Manhattan plot of resistance to cardiomyopathy syndrome (CMS). (**A**) Binary phenotype recorded from field outbreak on the commercial farm population 1. (**B**) Binary phenotype recorded from field outbreak of the informant pedigreed population 2. (**C**) Histology score of heart tissue (atrium) based on challenge test information of the informant pedigreed population 3. Red and blue horizontal line represent genome-wide significant threshold ($- log_{10}P = 6.03$) and chromosomal-wide significant threshold for the population ($- log_{10}P = 4.56$), respectively. See online version for full colors.](esz042f0002){#F2}

![Quantile--quantile plot of $- log_{10}P$ values for each of the 3 populations. See online version for full colors.](esz042f0003){#F3}

![Manhattan plots of chromosome 12 and 27 for the 3 populations; (**a**), (**b**), (**c**), and (**d**) are plots from population 1; (**e**) and (**f**) are plots from population 2; and (**g**), (**h**), (**i**), and (**j**) are plots from population 3. Plots (b), (d), (f), (h), and (j) were obtained by fitting the top most significant marker as covariate in the genome-wide association analysis. Red and blue horizontal line represent the genome-wide significant threshold ($- log_{10}P = 6.03$) and the chromosomal-wide significant threshold for the population ($- log_{10}P = 4.56$), respectively. See online version for full colors.](esz042f0004){#F4}

For population 1, 1 marker on chromosome 12 (located at 67,351,339 bps) and 9 markers on chromosome 27 (spanned from 10,023,660 to 16,436,601 bps) exceeded the genome-wide threshold ([Figures 2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}). The most significant marker for population 1 on chromosome 27 was located at 11,724,500 bps ([Table 4](#T4){ref-type="table"}). The frequency of the favorable allele for the top significant marker for chromosome 12 and 27 were 0.531 and 0.253, with each marker explaining about 12% and 14% of the total genetic variance, respectively.

###### 

Summary statistics of the most significant markers for the 3 populations

  Populations                    CHR   Position (bp)   SNP           A1   A2   Freq (A1)   Beta (A1)   *P*-value   Vg^1^   Vp^2^
  ------------- ---------------- ----- --------------- ------------- ---- ---- ----------- ----------- ----------- ------- -------
  1             Production       12    67351339        AX-96382208   B    A    0.469       −0.159      2.81E−07    0.120   0.049
                                 27    11724500        AX-96420652   B    A    0.253       0.197       2.15E−08    0.140   0.057
  2             Informant        27    10160666        AX-86985828   A    B    0.157       −0.055      1.32E−08    0.079   0.009
  3             Challenge test   12    62828648        AX-96152485   B    A    0.412       0.216       1.79E−08    0.101   0.046
                                 27    11723738        AX-97886034   A    B    0.397       −0.384      6.98E−27    0.317   0.145

^1^Proportion of the genetic (V~g~) and ^2^phenotypic (V~p~) variance explained by the most significant markers.

For population 2, 4 markers on chromosome 27 were significant, while none of the markers on chromosome 12 was significant ([Figures 2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}). Three of these markers spanned from 10,160,666 to 10,781,998 bps (a region of 621,332 bps), while the other marker was located at 29,548,089 bps. The most significant marker (*P* = 1.322 × 10^−8^) was located at 10,160,666 bps and it explained 7.9% of the total genetic variance.

For population 3, the QTL peaks on chromosome 12 and 27 were very strong ([Figures 2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"}), with 175 markers exceeding the Bonferroni threshold. Out of the 175 significant markers, 11 and 164 markers were on chromosome 12 and 27, respectively. The most significant marker (*P* = 6.9751 × 10^−27^) for this population was also on chromosome 27 and was located at 11,723,738 bps. The frequency of the favorable allele was 0.397 and it explained 31.7% and 14.5% of the total genetic and phenotypic variance. The entire region on chromosome 27 spanned from 6,292,857 to 35,401,496 bps. Six out of the 11 markers on chromosome 12 spanned a region of 236,290 bps (between 62,592,358 and 62,828,648 bps) and the most significant marker (*P* = 1.7943 × 10^−8^ and at 62,828,648 bps) was located within this region. This marker explained 10.1% of the total genetic variance ([Table 4](#T4){ref-type="table"}).

Comparing the most significant marker from one population to the other, we observed a consistent direction (positive or negative) of the allele substitution effect in all the populations, although in some cases the marker was not significant ($- log_{10}P = 6.03$) ([Table 5](#T5){ref-type="table"}).

###### 

Summary statistics of the 5 significant markers in all the 3 population

  Chromosome   SNP           Position(bps)   A1   A2   Freq (A1)   beta (A1)   *P*-value   Population^1^    Population marker was significant
  ------------ ------------- --------------- ---- ---- ----------- ----------- ----------- ---------------- -----------------------------------
  27           AX-86985828   10160666        A    B    0.157       −0.055      1.32E−08    Informant        informant
  27           AX-86985828   10160666        A    B    0.383       −0.145      1.26E−05    Production       informant
  27           AX-86985828   10160666        A    B    0.141       0.110       2.28E−02    Challenge test   informant
  12           AX-96382208   67351339        B    A    0.542       −0.003      6.82E−01    Informant        Production
  12           AX-96382208   67351339        B    A    0.469       −0.159      2.81E−07    Production       Production
  12           AX-96382208   67351339        B    A    0.263       0.213       7.69E-07    Challenge test   Production
  27           AX-96420652   11724500        A    B    0.382       −0.009      2.28E−01    Informant        Production
  27           AX-96420652   11724500        A    B    0.747       −0.197      2.15E−08    Production       Production
  27           AX-96420652   11724500        A    B    0.329       0.293       1.26E−16    Challenge test   Production
  12           AX-96152485   62828648        A    B    0.289       0.006       3.98E−01    Informant        Challenge test
  12           AX-96152485   62828648        A    B    0.359       0.045       1.59E−01    Production       Challenge test
  12           AX-96152485   62828648        A    B    0.587       −0.216      1.79E−08    Challenge test   Challenge test
  27           AX-97886034   11723738        A    B    0.310       0.021       1.06E−02    Informant        Challenge test
  27           AX-97886034   11723738        A    B    0.132       0.235       4.29E−08    Production       Challenge test
  27           AX-97886034   11723738        A    B    0.397       −0.384      6.98E−27    Challenge test   Challenge test

^1^Binary phenotype (dead = 0 and survived = 1) was used in population 1 (Production) and 2 (informant), histology score of the heart (atrium) was the recorded phenotype in population 3 (Challenge test).

Most of the significant SNPs were located within genes, including UTRs, introns, exons, and intergenic regions ([Supplementary File 2](#sup2){ref-type="supplementary-material"}). Thirty-six of the SNP markers resided within exons and 18 of them would cause amino acid changes. Genes located within ± 50 kbs of the top significant markers obtained from the association analysis of the 3 populations were investigated. In all, 4 distinct 50 kb regions around the most significant markers were investigated ([Table 6](#T6){ref-type="table"}). On chromosome 12, 2 QTL regions (region 12_1: 62,778,648 to 62,878,648 bps and region 12_2: 67,301,339 to 67,401,339 bps) were defined based on the top significant SNP that was obtained in population 1 and 3. Two QTL regions were also defined for chromosome 27; region 27_1 and 27_2 spanned from 10,110,666 to 10,210,666 bps (population 2) and 11,674,500 to 11,774,500 bps (population 1 and 3), respectively.

###### 

Genes located close to the top significant markers of chromosome 12 and 27 for the 3 population

  Chromosome   QTL region^1^                             Population                      Gene           Gene name
  ------------ --------------- ------------ ------------ ------------------------------- -------------- --------------------------------------------------------------------------------------------
  12           SSA12_1         62,778,648   62,878,648   Challenge test                  LOC106565906   Draxin-A
                                                                                         LOC106565953   Uncharacterized LOC106565953
                                                                                         LOC106565907   Pantothenate kinase 4-like (PANK4)
                                                                                         LOC100353126   Angiotensin II receptor associated protein (AGTRAP)
               SSA12_2         67,301,339   67,401,339   Informant                       LOC106565841   Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like ((MAGI1)
  27           SSA27_1         10,110,666   10,210,666   Informant                       LOC100136924   Transport-associated protein 2b (TAP2B)
                                                                                         LOC106588399   Proteasome subunit beta type-6-a like protein-like (PSMB6-A)
                                                                                         LOC100136936   Proteasome subunit beta type-9a (PSMB9-A)
                                                                                         LOC106588263   Uncharacterized LOC106588263
                                                                                         LOC106588398   Proteasome subunit beta type-7-like
                                                                                         LOC106455085   Transfer RNA valine (anticodon GAC) (TRNAV-GAC)
                                                                                         LOC106588400   Proteasome subunit beta type-8-like
                                                                                         LOC106588401   Class I histocompatibility antigen, F10 alpha chain-like (HFA1)
               SSA27_2         11,674,500   11,774,500   Challenge test and Production   LOC106588340   Phosphatidylinositol 4-kinase beta (PI4KB)
                                                                                         LOC106588342   Protein prune homolog
                                                                                         LOC106588341   Protein FAM63A-like
                                                                                         LOC106588344   Guanine nucleotide-binding protein G(s) subunit alpha pseudogene (GNAS)
                                                                                         LOC106588343   BCL2/adenovirus E1B 19 kDa protein-interacting protein 2-like (BNIP2)
                                                                                         LOC106588345   CDC42 small effector protein 1-like

^1^QTL region was defined as ± 50 kbs to the left and right of the most significant SNP in each population.

Several interesting genes with functions known to affect viral resistance were found to map to the QTL regions ([Table 6](#T6){ref-type="table"}). The *magi1* gene (membrane-associated guanylate kinase, WW, and PDZ domain containing 1) was the only gene in region 12_2. The class I histocompatibility antigen, F10 alpha chain-like (*ha1f*) gene was found in region 27_1. Genes in region 27_2 included the transcript for phosphatidylinositol 4-kinase beta (*pi4kb*) and BCL2/adenovirus E1B 19 kDa protein-interacting protein 2-like (*bnip2*).

Discussion {#s15}
==========

The main aim of this study was to estimate heritability and to detect QTLs for CMS resistance in 3 different year-class populations of Atlantic salmon. The recorded data used was binary survival data from field outbreaks (2 of the populations) and atrium-score data from a challenge test (the third population). In addition, we estimated the magnitude of the genetic correlations between the 3 mentioned traits in these populations. We obtained low to high heritability estimates (0.12--0.46) with survival data from field outbreaks and challenge test experiments. A moderate and favorable genetic correlation was obtained between the traits from the 3 populations. The genome-wide association study identified a putative QTL on chromosome 27 in all 3 populations and on chromosome 12 in 2 of the populations. Both QTLs explained about 7.6% to 31.7% of the total genetic variance and about 1% to 14.5% of the phenotypic variance. Functionally interesting candidate causative genes (*hfa1* and *bnip2*) were found to map near to the SNPs that were most significant.

Heritability of Resistance to CMS Infection {#s16}
-------------------------------------------

Low to moderate heritability was estimated for survival (0.38 ± 0.08 for population 1 and 0.12 ± 0.02 for population 2) while higher heritability was estimated for the atrium-score trait (0.46 ± 0.06). The higher heritability estimates for survival in population 1 may be due to the much higher mortality (55.7%) than in population 2 (9.3%). When the 2 binary heritability estimates were transformed to the underlying liability scale according to [@CIT0008], heritability estimate were 0.61 for population 1 and 0.36 for population 2. The lower heritability estimates in population 2 may be due to a relatively higher number of noninformative (zero mortality) families ([@CIT0025]) as well as the different sampling procedures used to collect data from the 2 populations. While those of population 2 were the survivors of the entire seawater period, the 300 survivors of population 1 were sampled and critically examined not to be infected with the PMCV virus after an equal number of dead fish had been recorded during a 6 weeks CMS outbreak. The heritability estimates for survival in population 1 are likely to be more specific estimates of the susceptibility to CMS than those for survival in population 2. In addition, some of the mortalities recorded in population 2 could have been due to causes other than CMS. This might be part of the reason for the relatively moderate genetic correlation (0.61 ± 0.23) detected between survival to CMS in the 2 populations. For this reason, the sampling strategy and the survival data from population 1 probably yields more power for mapping QTL affecting the susceptibility to CMS than the survival data from population 2. Nonetheless, the magnitude of the heritability estimates in all 3 populations confirm that there is substantial genetic variation in susceptibility to CMS and that genomic or marker-assisted selection could be effectively used to improve the resistance of Atlantic salmon to the PMCV virus. Moreover, the heritability estimates in this study are of a similar level to those detected for several other disease traits in Atlantic salmon (see the review by [@CIT0037]).

There are challenges with using field outbreak information from commercial populations for heritability estimation and mapping QTLs. First, it can be difficult to identify cause-specific mortalities (exact cause of death). Furthermore, without genomic information, it would not be possible to estimate heritability from commercial populations with unknown pedigree. The fish in commercial cages might have been produced from a few sires and dams, and therefore even with known pedigree, the estimate of heritability might not be very reliable. However, with genomic information, it is possible to estimate heritability from nonpedigreed populations as well as from populations with very few families and large number of offspring per family ([@CIT0023]). Although estimate of heritability from genome-wide identity-by-state markers can be biased upwards ([@CIT0010]). Finally, field outbreaks might not provide regular mortality information and could therefore be unreliable for routine selection of breeding candidates ([@CIT0003]; [@CIT0037]).

Genetic Correlations Between Traits from the Different Populations {#s17}
------------------------------------------------------------------

At first glance, the favorable but moderate genetic correlation of atrium histology scores with survival due to CMS outbreak in the field (population 1 and 2) indicates that the histology score of the atrium is not a good predictor of survival to CMS in the field. However, to better estimate the genetic correlation between survival and atrium histology score, these 2 traits should be measured on the same individuals or siblings, so that the magnitude of the correlation is not influenced by relatedness between independent populations which was the case in this study.

The moderate genetic correlation observed between populations may also be because the populations are different year-classes of Atlantic salmon established from different genetic bases during the late 1960's and early 1970's with little flow of genetic material and relatively low genetic connectedness between the 2 populations. This explains the population stratification that was evident from the principal component analysis ([Supplementary File 1](#sup2 sup3 sup4){ref-type="supplementary-material"}). Furthermore, a moderate genetic correlation between populations may be obtained because 1) linkage disequilibrium between markers and QTL could be different between populations and 2) markers associated with the QTL could differ in allele frequency between the populations. The magnitude of the genetic correlations between populations for a specific trait also reflects the expected genomic prediction potential across populations. ([@CIT0026]) reported that accuracies were 50% less when the genetic correlation between 2 breeds was 0.5 instead of 1. In this study, we computed the genetic correlations using all markers, however, since the LD phase between QTL and markers could be more persistent at causal loci (i.e., estimated allele substitution effect are similar and in the same direction) than at noncasual loci ([@CIT0036]; [@CIT0026]), we also investigated the effect of using only markers on chromosome 27 to construct the genomic relationship matrix and compute the genetic correlations between populations. This approach will estimate the genetic correlation between the marker effect of the 2 QTL region/chromosome between the population. The estimated genetic correlation using these 2 chromosomal regions was \~1.0 between population 1 and 2, −0.79 between population 1 and 3 and −0.59 between population 2 and 3. An increase in the estimate of genetic correlations between populations when casual variants are used compared to all loci have previously been observed in other studies ([@CIT0026]).

Putative QTL Positions {#s18}
----------------------

*P*-values in this study were inflated ($\lambda > 1.1$ for population 1 and 2), however, this is to be expected for structured populations with large full- and half-sib families ([@CIT0039]).

We observed 2 regions on chromosome 27 that were highly associated with resistance to CMS, however, since the power to detect QTLs for resistance to CMS was much larger in population 1 and 3 than in population 2, it is more likely that the causal mutation is located close to the 11.72 Mbps region than the 10.16 Mbp region. For chromosome 12, 2 regions were identified in population 1 (62828648 bps) and 3 (67351339 bps), and these 2 regions were 4.5 Mbps apart. The reasons for the discrepancies in the location of the top significant markers on chromosomes 12 and 27 are difficult to explain. For example, the top significant marker of population 1 (AX-86985828, with frequency of allele B equal to 0.16), was equally frequent in population 3 (frequency of allele B equal to 0.14), but this marker was not significant in population 3. We speculate that, the reason for these discrepancies is because the markers on this SNP array are not in complete linkage disequilibrium with the QTL. Therefore, fine mapping of these regions with sequence information should be undertaken to narrow down the QTL region and possibly identify the causative gene and the quantitative trait nucleotides.

There was consistency in the direction of the allele substitution effects in the 3 populations and this suggests that, the LD phase between the markers and the causative mutation is in the same direction in the 3 populations, however, since allele frequencies differ, the magnitude of the allele substitution effect and the proportion of variance explained by the QTL region is expected to be different in the 3 populations.

The QTL region on chromosome 27 explained \~30% of the total genetic variance (results from the challenge test). Several medium to large QTLs have also been found for several disease traits in Atlantic salmon such as pancreas disease ([@CIT0013]) and infectious pancreatic necrosis ([@CIT0017]; [@CIT0021]). Using the top marker as a covariate before computing the allele substitution effect of all other markers on chromosome 27 removed the QTL peak ([Figure 4](#F4){ref-type="fig"}). This is an indication that, the top significant marker can be used to tag the QTL and can be used for marker-assisted selection (MAS). Therefore, classical family-based selective breeding, supplemented with MAS to capitalize on the genetic variation within families, can be used as one of the strategies to combat this disease. Application of marker-assisted selection to selective breeding utilizing marker genotypes for these large QTLs have led to substantial increases in genetic gain in some Atlantic salmon breeding programs ([@CIT0030]).

Genes Located in the QTL Region {#s19}
-------------------------------

Several genes with functions potentially affecting viral resistance were found to map to the regions identified. In mammals, the PDZ1 and PDZ3 domains of the *magi1* gene have been shown to regulate the amount of coxsackievirus and adenovirus receptor (*car*), which directly impacts pathogenicity of these viruses ([@CIT0019]). The *ha1f* gene is part of the major histocompatibility complex class 1 (*mr1*) family of genes. The *mr1* (LOC106588402) gene was only 109 kbs away from the top significant marker of population 1. Specific alleles of *mhc* I and II have been found to be associated with resistance to infectious salmon anemia in Atlantic salmon ([@CIT0018]; [@CIT0014]). The product of *pi4kb* has been found to be important in viral replication for several types of viruses ([@CIT0007]). One particular virus, Coxsackievirus, produces a similar phenotype, myocarditis, in humans, and *pi4kb* is associated with resistance/susceptibility to Coxsackievirus infection in humans ([@CIT0009]). The *bcl2*/adenovirus E1B 19 kDa protein-interacting protein 2-like (*bnip2*) interacts with a protein responsible for the protection of virally induced cell death, and with *cdc42*, a gene which was also found to map in close proximity to QTL 27_2 ([@CIT0004]). In the absence of E1B-19k, cellular and viral DNA degradation occurs, and the death of viral host cells is promoted, and both these actions inhibit viral replication ([@CIT0035]). All these genes warrant further attention as potential candidates affecting viral immune function.

Conclusion {#s20}
==========

Our results from field outbreaks and challenge tests show that resistance to CMS in Atlantic salmon is heritable (0.12--0.46), and that breeding populations could be selected for improved CMS resistance to help reduce outbreaks of the disease. We also identified 2 QTL regions on chromosome 27 and 12 across all 3 populations which explained 7.6% to 31.7% of the total genetic variance. Interesting genes mapping to these QTL regions that could play a role in resistance to CMS included *magi1*, *pi4kb*, *bnip2*, and *ha1f*. These results also highlight the potential of using field outbreak information from nonpedigreed populations to estimate heritability and map QTLs in Atlantic salmon populations.

Funding {#s0100}
=======

This work was partly funded by the Norwegian Research Council, project number 254880.

Data Availability {#s0101}
=================

The datasets used in this study were from a private breeding company, therefore we are not permitted to share phenotypic and genotypic data directly, however, data is available upon request from the corresponding author.

Supplementary Material
======================

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

We thank Mowi Genetics As for providing us with genotype data of population 2 and 3. The ASreml analysis was performed on the Abel Cluster (<http://www.hpc.uio.no/>).
